Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis.

[1]  Robert L. Goldstone,et al.  Microbe capture by splenic macrophages triggers sepsis via T cell-death-dependent neutrophil lifespan shortening , 2022, Nature Communications.

[2]  L. Broderick,et al.  IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting , 2022, Nature Reviews Rheumatology.

[3]  K. Roemer,et al.  Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study , 2022, The Lancet Rheumatology.

[4]  M. Netea,et al.  Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis , 2021, The Lancet Rheumatology.

[5]  W. Schaffner,et al.  The landscape of candidemia during the COVID-19 pandemic. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Stone,et al.  Neutralizing Anti-Interleukin-1 Receptor-Antagonist Autoantibodies Induce Inflammatory and Fibrotic Mediators in IgG4-Related Disease. , 2021, The Journal of allergy and clinical immunology.

[7]  I. Mellman,et al.  IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines , 2022, Nature Immunology.

[8]  R. Medzhitov,et al.  Tissue Homeostasis and Inflammation. , 2021, Annual review of immunology.

[9]  James S Griffiths,et al.  Role for IL-1 Family Cytokines in Fungal Infections , 2021, Frontiers in Microbiology.

[10]  A. Puel.  Human inborn errors of immunity underlying superficial or invasive candidiasis , 2020, Human Genetics.

[11]  C. Gabay,et al.  Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α , 2020, The Journal of Immunology.

[12]  L. Chatenoud,et al.  Chronic Disseminated Candidiasis During Hematological Maligancies: An Immune Reconstitution Inflammatory Syndrome with Expansion of Pathogen-Specific TH1 T Cells. , 2019, The Journal of infectious diseases.

[13]  S. Matalon,et al.  IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation. , 2019, JCI insight.

[14]  K. Schroder,et al.  Inflammasome signaling and regulation of interleukin-1 family cytokines , 2019, The Journal of experimental medicine.

[15]  N. Mukaida,et al.  Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by interleukin-1 receptor antagonist IL-1Ra , 2019, Nature Microbiology.

[16]  C. Garlanda,et al.  Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. , 2019, Immunity.

[17]  D. Kontoyiannis,et al.  Invasive fungal disease and cytomegalovirus infection: is there an association? , 2018, Current opinion in infectious diseases.

[18]  L. Chatenoud,et al.  Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections , 2018, Journal of fungi.

[19]  M. Lionakis,et al.  The Role of Neutrophils in Host Defense Against Invasive Fungal Infections , 2018, Current Clinical Microbiology Reports.

[20]  B. Kullberg,et al.  Invasive Candidiasis. , 2019, The New England journal of medicine.

[21]  M. Lionakis,et al.  Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts. , 2018, Annual review of immunology.

[22]  N. Reich,et al.  Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection , 2018, mBio.

[23]  M. Donath,et al.  β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion. , 2018, Cell reports.

[24]  C. Ardavı́n,et al.  Inflammatory Ly6Chigh Monocytes Protect against Candidiasis through IL‐15‐Driven NK Cell/Neutrophil Activation , 2017, Immunity.

[25]  M. Netea,et al.  The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.

[26]  A. Warnatsch,et al.  Reactive Oxygen Species Localization Programs Inflammation to Clear Microbes of Different Size , 2017, Immunity.

[27]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[28]  Xiaodi Wu,et al.  Mafb lineage tracing to distinguish macrophages from other immune lineages reveals dual identity of Langerhans cells , 2016, The Journal of experimental medicine.

[29]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[30]  K. Mayer-Barber,et al.  Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses , 2016, Cellular & Molecular Immunology.

[31]  Mathias Müller,et al.  Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue. , 2016, Cell host & microbe.

[32]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[33]  Richard L. Amdur,et al.  Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial* , 2016, Critical care medicine.

[34]  C. Gabay,et al.  The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. , 2015, Cytokine.

[35]  L. Joosten,et al.  Immune defence against Candida fungal infections , 2015, Nature Reviews Immunology.

[36]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[37]  B. Barker,et al.  IL-1α Signaling Is Critical for Leukocyte Recruitment after Pulmonary Aspergillus fumigatus Challenge , 2015, PLoS pathogens.

[38]  A. Sher,et al.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk , 2014, Nature.

[39]  J. Ruland,et al.  Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. , 2013, Immunity.

[40]  E. Latz,et al.  Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.

[41]  Alexander Hoischen,et al.  Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans , 2013, Nature Communications.

[42]  David W. Denning,et al.  Hidden Killers: Human Fungal Infections , 2012, Science Translational Medicine.

[43]  K. Kuchler,et al.  Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida Infections , 2012, PLoS pathogens.

[44]  S. Gringhuis,et al.  Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome , 2012, Nature Immunology.

[45]  Alessandro Costa,et al.  Recognition of yeast nucleic acids triggers a host‐protective type I interferon response , 2011, European journal of immunology.

[46]  Gordon D. Brown.  Innate antifungal immunity: the key role of phagocytes. , 2011, Annual review of immunology.

[47]  Pedro Romero,et al.  Type I interferon inhibits interleukin-1 production and inflammasome activation. , 2011, Immunity.

[48]  C. Gabay,et al.  Distinct Roles of Hepatocyte- and Myeloid Cell-Derived IL-1 Receptor Antagonist during Endotoxemia and Sterile Inflammation in Mice , 2010, The Journal of Immunology.

[49]  S. Akira,et al.  Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. , 2010, Immunity.

[50]  C. Gabay,et al.  Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. , 2010, Arthritis and rheumatism.

[51]  P. Gregersen,et al.  An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. , 2009, The New England journal of medicine.

[52]  J. Tschopp,et al.  Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence , 2009, Nature.

[53]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[54]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[55]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[56]  M. Netea,et al.  Endogenous Interleukin (IL)–1α and IL-1β Are Crucial for Host Defense against Disseminated Candidiasis , 2006 .

[57]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  A. Mantovani,et al.  The Contribution of the Toll-Like/IL-1 Receptor Superfamily to Innate and Adaptive Immunity to Fungal Pathogens In Vivo1 , 2004, The Journal of Immunology.

[59]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[60]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[61]  M. Dorf,et al.  Isolation of Mouse Neutrophils , 1997, Current protocols in immunology.

[62]  K. Matsushima,et al.  Preparation of specific antibodies against murine IL‐1ra and the establishment of IL‐1ra as an endogenous regulator of bacteria‐induced fulminant hepatitis in mice , 1995, Journal of leukocyte biology.

[63]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[64]  B. Kullberg,et al.  Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1 , 1990, Infection and immunity.

[65]  N. Rooijen,et al.  Macrophage Subset Repopulation in the Spleen: Differential Kinetics After Liposome‐Mediated Elimination , 1989, Journal of leukocyte biology.

[66]  C. Dinarello,et al.  Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1 , 1988, European journal of immunology.

[67]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[68]  L. Romani.  Immunity to fungal infections , 2011, Nature Reviews Immunology.

[69]  C. Gabay,et al.  Interleukin-1 receptor antagonist: role in biology. , 1998, Annual review of immunology.